FGP
UPB

Freestone Grove Partners’s Upstream Bio Inc UPB Stock Holding History

Freestone Grove Partners’s Portfolio UPB Stock Details UPB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7 Hold
1
– – ﹤0.01% 977
2026
Q1 		$9 Buy
+1
New +$18 ﹤0.01% 950

Other funds holding UPB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Freestone Grove Partners's UPB Position: Q2 2026 in Review

Freestone Grove Partners held its Upstream Bio Inc (UPB) position steady in Q2 2026 at 1 share worth $7. The position accounts for ﹤0.01% of the portfolio, ranked #977.

Freestone Grove Partners first reported a position in UPB in Q1 2026 and has held it in 2 quarters since. The position peaked at $9 in Q1 2026. 149 funds tracked by Wall St. Rank hold UPB as of Q2 2026.

  • Freestone Grove Partners held 1 share of Upstream Bio Inc worth $7 as of Q2 2026.
  • Freestone Grove Partners left its Upstream Bio Inc share count unchanged in Q2 2026.
  • Upstream Bio Inc made up ﹤0.01% of Freestone Grove Partners's portfolio in Q2 2026, its #977 holding.
  • Freestone Grove Partners first reported a position in Upstream Bio Inc in Q1 2026 and has held it in 2 quarters since.
  • Freestone Grove Partners's Upstream Bio Inc position peaked at $9 in Q1 2026.
  • 149 funds tracked by Wall St. Rank held Upstream Bio Inc as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.